nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—ANXA1—lung cancer	0.174	0.442	CbGaD
Dexamethasone—CYP2A6—lung cancer	0.0533	0.136	CbGaD
Dexamethasone—ABCG2—lung cancer	0.0477	0.121	CbGaD
Dexamethasone—CYP2E1—lung cancer	0.0379	0.0963	CbGaD
Dexamethasone—CYP1A1—lung cancer	0.0374	0.095	CbGaD
Dexamethasone—NOS2—Doxorubicin—lung cancer	0.0259	0.0644	CbGbCtD
Dexamethasone—PTGS2—lung cancer	0.0234	0.0594	CbGaD
Dexamethasone—CYP4A11—Cisplatin—lung cancer	0.0222	0.0552	CbGbCtD
Dexamethasone—ABCB1—lung cancer	0.0199	0.0505	CbGaD
Dexamethasone—CYP1B1—Erlotinib—lung cancer	0.0125	0.0311	CbGbCtD
Dexamethasone—ABCB11—Paclitaxel—lung cancer	0.0114	0.0285	CbGbCtD
Dexamethasone—CYP1B1—Paclitaxel—lung cancer	0.0114	0.0285	CbGbCtD
Dexamethasone—ABCG2—Topotecan—lung cancer	0.011	0.0274	CbGbCtD
Dexamethasone—ABCG2—Gefitinib—lung cancer	0.0101	0.025	CbGbCtD
Dexamethasone—ABCB11—Vinblastine—lung cancer	0.01	0.025	CbGbCtD
Dexamethasone—ABCG2—Teniposide—lung cancer	0.00975	0.0243	CbGbCtD
Dexamethasone—CYP1A1—Gefitinib—lung cancer	0.00928	0.0231	CbGbCtD
Dexamethasone—CYP19A1—Paclitaxel—lung cancer	0.00928	0.0231	CbGbCtD
Dexamethasone—CYP1B1—Docetaxel—lung cancer	0.00828	0.0206	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—lung cancer	0.00617	0.0154	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—lung cancer	0.00617	0.0154	CbGbCtD
Dexamethasone—ABCC2—Paclitaxel—lung cancer	0.00602	0.015	CbGbCtD
Dexamethasone—ABCG2—Erlotinib—lung cancer	0.00595	0.0148	CbGbCtD
Dexamethasone—ABCC2—Irinotecan—lung cancer	0.00594	0.0148	CbGbCtD
Dexamethasone—CYP3A5—Gefitinib—lung cancer	0.00557	0.0139	CbGbCtD
Dexamethasone—CYP1A1—Erlotinib—lung cancer	0.00549	0.0137	CbGbCtD
Dexamethasone—ABCG2—Paclitaxel—lung cancer	0.00544	0.0135	CbGbCtD
Dexamethasone—CYP3A5—Teniposide—lung cancer	0.0054	0.0134	CbGbCtD
Dexamethasone—ABCG2—Irinotecan—lung cancer	0.00537	0.0134	CbGbCtD
Dexamethasone—ABCC2—Vinblastine—lung cancer	0.00528	0.0131	CbGbCtD
Dexamethasone—ABCC2—Cisplatin—lung cancer	0.00484	0.0121	CbGbCtD
Dexamethasone—PTGS2—Cisplatin—lung cancer	0.00478	0.0119	CbGbCtD
Dexamethasone—ABCC2—Etoposide—lung cancer	0.00476	0.0118	CbGbCtD
Dexamethasone—PTGS2—Etoposide—lung cancer	0.0047	0.0117	CbGbCtD
Dexamethasone—CYP2C19—Gefitinib—lung cancer	0.00449	0.0112	CbGbCtD
Dexamethasone—ABCG2—Cisplatin—lung cancer	0.00438	0.0109	CbGbCtD
Dexamethasone—CYP2C19—Teniposide—lung cancer	0.00436	0.0108	CbGbCtD
Dexamethasone—ABCC2—Docetaxel—lung cancer	0.00435	0.0108	CbGbCtD
Dexamethasone—ABCG2—Etoposide—lung cancer	0.0043	0.0107	CbGbCtD
Dexamethasone—CYP3A7—Paclitaxel—lung cancer	0.00402	0.01	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00402	0.01	CbGbCtD
Dexamethasone—CYP3A7—Irinotecan—lung cancer	0.00397	0.00987	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.00397	0.00987	CbGbCtD
Dexamethasone—ABCB1—Topotecan—lung cancer	0.00396	0.00987	CbGbCtD
Dexamethasone—ABCG2—Docetaxel—lung cancer	0.00394	0.00979	CbGbCtD
Dexamethasone—SLCO1A2—Methotrexate—lung cancer	0.00379	0.00944	CbGbCtD
Dexamethasone—CYP2B6—Irinotecan—lung cancer	0.00378	0.0094	CbGbCtD
Dexamethasone—CYP2C9—Gefitinib—lung cancer	0.00374	0.0093	CbGbCtD
Dexamethasone—ABCB1—Gefitinib—lung cancer	0.00363	0.00902	CbGbCtD
Dexamethasone—CYP2C9—Teniposide—lung cancer	0.00362	0.00902	CbGbCtD
Dexamethasone—CYP2D6—Gefitinib—lung cancer	0.00342	0.0085	CbGbCtD
Dexamethasone—CYP3A5—Crizotinib—lung cancer	0.00341	0.0085	CbGbCtD
Dexamethasone—CYP3A5—Erlotinib—lung cancer	0.00329	0.0082	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—lung cancer	0.00324	0.00808	CbGbCtD
Dexamethasone—CYP2C8—Erlotinib—lung cancer	0.00317	0.00788	CbGbCtD
Dexamethasone—ABCC2—Methotrexate—lung cancer	0.00314	0.00782	CbGbCtD
Dexamethasone—CYP2B6—Cisplatin—lung cancer	0.00308	0.00766	CbGbCtD
Dexamethasone—CYP2E1—Etoposide—lung cancer	0.00307	0.00763	CbGbCtD
Dexamethasone—CYP3A5—Paclitaxel—lung cancer	0.00302	0.00751	CbGbCtD
Dexamethasone—CYP3A5—Irinotecan—lung cancer	0.00297	0.0074	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—lung cancer	0.00293	0.0073	CbGbCtD
Dexamethasone—CYP3A7—Docetaxel—lung cancer	0.00291	0.00723	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00291	0.00723	CbGbCtD
Dexamethasone—CYP2C8—Paclitaxel—lung cancer	0.0029	0.00722	CbGbCtD
Dexamethasone—ABCG2—Methotrexate—lung cancer	0.00284	0.00707	CbGbCtD
Dexamethasone—ABCB1—Vinorelbine—lung cancer	0.00279	0.00695	CbGbCtD
Dexamethasone—CYP2D6—Vinorelbine—lung cancer	0.00263	0.00655	CbGbCtD
Dexamethasone—CYP3A5—Etoposide—lung cancer	0.00238	0.00593	CbGbCtD
Dexamethasone—CYP3A4—Topotecan—lung cancer	0.00238	0.00591	CbGbCtD
Dexamethasone—CYP2C8—Etoposide—lung cancer	0.00229	0.0057	CbGbCtD
Dexamethasone—ABCB1—Crizotinib—lung cancer	0.00222	0.00553	CbGbCtD
Dexamethasone—CYP3A5—Docetaxel—lung cancer	0.00218	0.00543	CbGbCtD
Dexamethasone—CYP3A4—Gefitinib—lung cancer	0.00217	0.00541	CbGbCtD
Dexamethasone—ABCB1—Gemcitabine—lung cancer	0.00217	0.00541	CbGbCtD
Dexamethasone—ABCB1—Erlotinib—lung cancer	0.00214	0.00534	CbGbCtD
Dexamethasone—CYP3A4—Teniposide—lung cancer	0.00211	0.00524	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—lung cancer	0.00206	0.00513	CbGbCtD
Dexamethasone—CYP2C9—Paclitaxel—lung cancer	0.00202	0.00503	CbGbCtD
Dexamethasone—CYP2D6—Erlotinib—lung cancer	0.00202	0.00503	CbGbCtD
Dexamethasone—ABCB1—Paclitaxel—lung cancer	0.00196	0.00488	CbGbCtD
Dexamethasone—ABCB1—Irinotecan—lung cancer	0.00194	0.00482	CbGbCtD
Dexamethasone—ABCB1—Vinblastine—lung cancer	0.00172	0.00428	CbGbCtD
Dexamethasone—CYP3A4—Vinorelbine—lung cancer	0.00167	0.00417	CbGbCtD
Dexamethasone—CYP2C9—Cisplatin—lung cancer	0.00163	0.00405	CbGbCtD
Dexamethasone—CYP2D6—Vinblastine—lung cancer	0.00162	0.00404	CbGbCtD
Dexamethasone—ABCB1—Cisplatin—lung cancer	0.00158	0.00393	CbGbCtD
Dexamethasone—ABCB1—Etoposide—lung cancer	0.00155	0.00386	CbGbCtD
Dexamethasone—ABCB1—Docetaxel—lung cancer	0.00142	0.00353	CbGbCtD
Dexamethasone—CYP3A4—Crizotinib—lung cancer	0.00133	0.00331	CbGbCtD
Dexamethasone—CYP3A4—Erlotinib—lung cancer	0.00128	0.0032	CbGbCtD
Dexamethasone—NR0B1—respiratory system—lung cancer	0.00121	0.0604	CbGeAlD
Dexamethasone—CYP3A4—Paclitaxel—lung cancer	0.00118	0.00293	CbGbCtD
Dexamethasone—CYP3A4—Irinotecan—lung cancer	0.00116	0.00289	CbGbCtD
Dexamethasone—ABCB1—Doxorubicin—lung cancer	0.00106	0.00263	CbGbCtD
Dexamethasone—CYP3A4—Vinblastine—lung cancer	0.00103	0.00257	CbGbCtD
Dexamethasone—ABCB1—Methotrexate—lung cancer	0.00102	0.00255	CbGbCtD
Dexamethasone—CYP2D6—Doxorubicin—lung cancer	0.000997	0.00248	CbGbCtD
Dexamethasone—ANXA1—mammary gland—lung cancer	0.000987	0.0493	CbGeAlD
Dexamethasone—CYP3A4—Etoposide—lung cancer	0.000929	0.00231	CbGbCtD
Dexamethasone—PLA2G1B—respiratory system—lung cancer	0.00086	0.043	CbGeAlD
Dexamethasone—CYP3A4—Docetaxel—lung cancer	0.00085	0.00212	CbGbCtD
Dexamethasone—PLA2G1B—epithelium—lung cancer	0.000719	0.0359	CbGeAlD
Dexamethasone—ANXA1—respiratory system—lung cancer	0.000658	0.0329	CbGeAlD
Dexamethasone—NR0B1—lung—lung cancer	0.000641	0.032	CbGeAlD
Dexamethasone—CYP3A4—Doxorubicin—lung cancer	0.000634	0.00158	CbGbCtD
Dexamethasone—Amcinonide—ANXA1—lung cancer	0.000611	0.39	CrCbGaD
Dexamethasone—PGR—mammary gland—lung cancer	0.000594	0.0297	CbGeAlD
Dexamethasone—ANXA1—epithelium—lung cancer	0.00055	0.0275	CbGeAlD
Dexamethasone—ANXA1—bronchus—lung cancer	0.000541	0.0271	CbGeAlD
Dexamethasone—CYP1B1—mammary gland—lung cancer	0.0005	0.025	CbGeAlD
Dexamethasone—ANXA1—trachea—lung cancer	0.000486	0.0243	CbGeAlD
Dexamethasone—PLA2G1B—lung—lung cancer	0.000457	0.0228	CbGeAlD
Dexamethasone—ANXA1—cardiac atrium—lung cancer	0.000457	0.0228	CbGeAlD
Dexamethasone—PGR—respiratory system—lung cancer	0.000396	0.0198	CbGeAlD
Dexamethasone—ANXA1—bone marrow—lung cancer	0.000386	0.0193	CbGeAlD
Dexamethasone—CYP2C8—mammary gland—lung cancer	0.000383	0.0191	CbGeAlD
Dexamethasone—NR3C2—bronchus—lung cancer	0.000351	0.0175	CbGeAlD
Dexamethasone—ANXA1—lung—lung cancer	0.000349	0.0175	CbGeAlD
Dexamethasone—CYP2C9—mammary gland—lung cancer	0.00034	0.017	CbGeAlD
Dexamethasone—CYP1B1—respiratory system—lung cancer	0.000333	0.0167	CbGeAlD
Dexamethasone—PGR—epithelium—lung cancer	0.000331	0.0165	CbGeAlD
Dexamethasone—NR3C2—trachea—lung cancer	0.000315	0.0157	CbGeAlD
Dexamethasone—NR3C2—cardiac atrium—lung cancer	0.000296	0.0148	CbGeAlD
Dexamethasone—Hydrocortisone—ANXA1—lung cancer	0.000257	0.165	CrCbGaD
Dexamethasone—CYP2A6—lung—lung cancer	0.000241	0.0121	CbGeAlD
Dexamethasone—ANXA1—lymph node—lung cancer	0.000239	0.0119	CbGeAlD
Dexamethasone—CYP1A1—respiratory system—lung cancer	0.000235	0.0118	CbGeAlD
Dexamethasone—CYP3A5—respiratory system—lung cancer	0.00023	0.0115	CbGeAlD
Dexamethasone—CYP2B6—respiratory system—lung cancer	0.000229	0.0114	CbGeAlD
Dexamethasone—NR3C1—respiratory system—lung cancer	0.000228	0.0114	CbGeAlD
Dexamethasone—NR3C2—lung—lung cancer	0.000226	0.0113	CbGeAlD
Dexamethasone—CYP2E1—respiratory system—lung cancer	0.000215	0.0107	CbGeAlD
Dexamethasone—CYP17A1—lymph node—lung cancer	0.000214	0.0107	CbGeAlD
Dexamethasone—PGR—lung—lung cancer	0.00021	0.0105	CbGeAlD
Dexamethasone—CYP11A1—lymph node—lung cancer	0.000199	0.00996	CbGeAlD
Dexamethasone—PTGS2—respiratory system—lung cancer	0.000198	0.00989	CbGeAlD
Dexamethasone—CYP1A1—epithelium—lung cancer	0.000197	0.00984	CbGeAlD
Dexamethasone—SLCO1A2—lung—lung cancer	0.000194	0.00969	CbGeAlD
Dexamethasone—CYP1A1—bronchus—lung cancer	0.000194	0.00969	CbGeAlD
Dexamethasone—NR3C1—epithelium—lung cancer	0.000191	0.00955	CbGeAlD
Dexamethasone—CYP2B6—bronchus—lung cancer	0.000188	0.00942	CbGeAlD
Dexamethasone—NR3C1—bronchus—lung cancer	0.000188	0.0094	CbGeAlD
Dexamethasone—CYP1B1—lung—lung cancer	0.000177	0.00884	CbGeAlD
Dexamethasone—CYP1A1—trachea—lung cancer	0.000174	0.0087	CbGeAlD
Dexamethasone—NR3C1—trachea—lung cancer	0.000169	0.00844	CbGeAlD
Dexamethasone—PTGS2—epithelium—lung cancer	0.000165	0.00826	CbGeAlD
Dexamethasone—CYP1A1—cardiac atrium—lung cancer	0.000163	0.00817	CbGeAlD
Dexamethasone—PTGS2—bronchus—lung cancer	0.000163	0.00814	CbGeAlD
Dexamethasone—NR3C1—cardiac atrium—lung cancer	0.000159	0.00793	CbGeAlD
Dexamethasone—NR3C2—lymph node—lung cancer	0.000155	0.00773	CbGeAlD
Dexamethasone—PTGS2—trachea—lung cancer	0.000146	0.00731	CbGeAlD
Dexamethasone—ABCG2—bone marrow—lung cancer	0.000145	0.00727	CbGeAlD
Dexamethasone—PGR—lymph node—lung cancer	0.000144	0.00719	CbGeAlD
Dexamethasone—NR3C1—bone marrow—lung cancer	0.000134	0.00669	CbGeAlD
Dexamethasone—ABCG2—lung—lung cancer	0.000132	0.00658	CbGeAlD
Dexamethasone—CYP19A1—lymph node—lung cancer	0.000129	0.00647	CbGeAlD
Dexamethasone—CYP1A1—lung—lung cancer	0.000125	0.00625	CbGeAlD
Dexamethasone—ABCC2—lymph node—lung cancer	0.000124	0.00618	CbGeAlD
Dexamethasone—ABCB1—respiratory system—lung cancer	0.000122	0.00611	CbGeAlD
Dexamethasone—CYP3A5—lung—lung cancer	0.000122	0.00611	CbGeAlD
Dexamethasone—CYP2B6—lung—lung cancer	0.000122	0.00607	CbGeAlD
Dexamethasone—NR3C1—lung—lung cancer	0.000121	0.00607	CbGeAlD
Dexamethasone—CYP1B1—lymph node—lung cancer	0.000121	0.00605	CbGeAlD
Dexamethasone—PTGS2—bone marrow—lung cancer	0.000116	0.00579	CbGeAlD
Dexamethasone—CYP2E1—lung—lung cancer	0.000114	0.0057	CbGeAlD
Dexamethasone—Clobetasol propionate—CYP1A1—lung cancer	0.00011	0.0704	CrCbGaD
Dexamethasone—PTGS2—lung—lung cancer	0.000105	0.00525	CbGeAlD
Dexamethasone—Prednisolone—CYP2A6—lung cancer	0.000103	0.066	CrCbGaD
Dexamethasone—ABCB1—epithelium—lung cancer	0.000102	0.00511	CbGeAlD
Dexamethasone—ABCB1—trachea—lung cancer	9.04e-05	0.00452	CbGeAlD
Dexamethasone—ABCG2—lymph node—lung cancer	9.01e-05	0.0045	CbGeAlD
Dexamethasone—CYP1A1—lymph node—lung cancer	8.55e-05	0.00428	CbGeAlD
Dexamethasone—NR3C1—lymph node—lung cancer	8.3e-05	0.00415	CbGeAlD
Dexamethasone—PTGS2—lymph node—lung cancer	7.18e-05	0.00359	CbGeAlD
Dexamethasone—ABCB1—bone marrow—lung cancer	7.17e-05	0.00358	CbGeAlD
Dexamethasone—Hydrocortisone—ABCG2—lung cancer	7.07e-05	0.0452	CrCbGaD
Dexamethasone—Fluticasone furoate—ABCB1—lung cancer	6.84e-05	0.0437	CrCbGaD
Dexamethasone—ABCB1—lung—lung cancer	6.49e-05	0.00325	CbGeAlD
Dexamethasone—Methylprednisolone—ABCB1—lung cancer	5.46e-05	0.0349	CrCbGaD
Dexamethasone—Triamcinolone—PTGS2—lung cancer	5.41e-05	0.0346	CrCbGaD
Dexamethasone—Myalgia—Paclitaxel—lung cancer	4.47e-05	0.000485	CcSEcCtD
Dexamethasone—Hypotension—Cisplatin—lung cancer	4.46e-05	0.000484	CcSEcCtD
Dexamethasone—Anxiety—Paclitaxel—lung cancer	4.46e-05	0.000483	CcSEcCtD
Dexamethasone—Erythema—Docetaxel—lung cancer	4.46e-05	0.000483	CcSEcCtD
Dexamethasone—Decreased appetite—Gemcitabine—lung cancer	4.45e-05	0.000483	CcSEcCtD
Dexamethasone—ABCB1—lymph node—lung cancer	4.44e-05	0.00222	CbGeAlD
Dexamethasone—Betamethasone—PTGS2—lung cancer	4.43e-05	0.0283	CrCbGaD
Dexamethasone—Nausea—Topotecan—lung cancer	4.43e-05	0.00048	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Gemcitabine—lung cancer	4.42e-05	0.000479	CcSEcCtD
Dexamethasone—Discomfort—Paclitaxel—lung cancer	4.42e-05	0.000479	CcSEcCtD
Dexamethasone—Fatigue—Gemcitabine—lung cancer	4.42e-05	0.000479	CcSEcCtD
Dexamethasone—Cardiac arrest—Doxorubicin—lung cancer	4.39e-05	0.000476	CcSEcCtD
Dexamethasone—Pain—Gemcitabine—lung cancer	4.38e-05	0.000475	CcSEcCtD
Dexamethasone—Nausea—Erlotinib—lung cancer	4.38e-05	0.000475	CcSEcCtD
Dexamethasone—Anaphylactic shock—Etoposide—lung cancer	4.38e-05	0.000474	CcSEcCtD
Dexamethasone—Mood swings—Doxorubicin—lung cancer	4.37e-05	0.000474	CcSEcCtD
Dexamethasone—Prednisone—ALB—lung cancer	4.37e-05	0.0279	CrCbGaD
Dexamethasone—Diarrhoea—Vinorelbine—lung cancer	4.36e-05	0.000473	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Cisplatin—lung cancer	4.35e-05	0.000472	CcSEcCtD
Dexamethasone—Infection—Etoposide—lung cancer	4.35e-05	0.000471	CcSEcCtD
Dexamethasone—Feeling abnormal—Irinotecan—lung cancer	4.33e-05	0.00047	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Irinotecan—lung cancer	4.3e-05	0.000466	CcSEcCtD
Dexamethasone—Oedema—Paclitaxel—lung cancer	4.29e-05	0.000465	CcSEcCtD
Dexamethasone—Anaphylactic shock—Paclitaxel—lung cancer	4.29e-05	0.000465	CcSEcCtD
Dexamethasone—Paraesthesia—Cisplatin—lung cancer	4.29e-05	0.000465	CcSEcCtD
Dexamethasone—Thrombocytopenia—Etoposide—lung cancer	4.28e-05	0.000464	CcSEcCtD
Dexamethasone—Tachycardia—Etoposide—lung cancer	4.27e-05	0.000463	CcSEcCtD
Dexamethasone—Infection—Paclitaxel—lung cancer	4.26e-05	0.000462	CcSEcCtD
Dexamethasone—Dry skin—Doxorubicin—lung cancer	4.23e-05	0.000459	CcSEcCtD
Dexamethasone—Hyperhidrosis—Etoposide—lung cancer	4.23e-05	0.000458	CcSEcCtD
Dexamethasone—Feeling abnormal—Gemcitabine—lung cancer	4.22e-05	0.000458	CcSEcCtD
Dexamethasone—Shock—Paclitaxel—lung cancer	4.22e-05	0.000457	CcSEcCtD
Dexamethasone—Dizziness—Vinorelbine—lung cancer	4.22e-05	0.000457	CcSEcCtD
Dexamethasone—Nervous system disorder—Paclitaxel—lung cancer	4.21e-05	0.000456	CcSEcCtD
Dexamethasone—Hypokalaemia—Doxorubicin—lung cancer	4.2e-05	0.000455	CcSEcCtD
Dexamethasone—Thrombocytopenia—Paclitaxel—lung cancer	4.2e-05	0.000455	CcSEcCtD
Dexamethasone—Tachycardia—Paclitaxel—lung cancer	4.19e-05	0.000454	CcSEcCtD
Dexamethasone—Prednisone—ABCB1—lung cancer	4.17e-05	0.0267	CrCbGaD
Dexamethasone—Anorexia—Etoposide—lung cancer	4.17e-05	0.000452	CcSEcCtD
Dexamethasone—Abdominal pain—Irinotecan—lung cancer	4.16e-05	0.000451	CcSEcCtD
Dexamethasone—Body temperature increased—Irinotecan—lung cancer	4.16e-05	0.000451	CcSEcCtD
Dexamethasone—Decreased appetite—Cisplatin—lung cancer	4.15e-05	0.00045	CcSEcCtD
Dexamethasone—Hyperhidrosis—Paclitaxel—lung cancer	4.15e-05	0.000449	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Cisplatin—lung cancer	4.12e-05	0.000447	CcSEcCtD
Dexamethasone—Anorexia—Paclitaxel—lung cancer	4.09e-05	0.000443	CcSEcCtD
Dexamethasone—Hypotension—Etoposide—lung cancer	4.09e-05	0.000443	CcSEcCtD
Dexamethasone—Pain—Cisplatin—lung cancer	4.08e-05	0.000443	CcSEcCtD
Dexamethasone—Muscular weakness—Doxorubicin—lung cancer	4.07e-05	0.000441	CcSEcCtD
Dexamethasone—Vomiting—Vinorelbine—lung cancer	4.05e-05	0.000439	CcSEcCtD
Dexamethasone—Body temperature increased—Gemcitabine—lung cancer	4.05e-05	0.000439	CcSEcCtD
Dexamethasone—Rash—Vinorelbine—lung cancer	4.02e-05	0.000436	CcSEcCtD
Dexamethasone—Dermatitis—Vinorelbine—lung cancer	4.02e-05	0.000435	CcSEcCtD
Dexamethasone—Hypotension—Paclitaxel—lung cancer	4.01e-05	0.000434	CcSEcCtD
Dexamethasone—Headache—Vinorelbine—lung cancer	4e-05	0.000433	CcSEcCtD
Dexamethasone—Syncope—Docetaxel—lung cancer	4e-05	0.000433	CcSEcCtD
Dexamethasone—Conjunctivitis—Methotrexate—lung cancer	3.99e-05	0.000433	CcSEcCtD
Dexamethasone—Feeling abnormal—Cisplatin—lung cancer	3.94e-05	0.000427	CcSEcCtD
Dexamethasone—Paraesthesia—Etoposide—lung cancer	3.93e-05	0.000426	CcSEcCtD
Dexamethasone—Loss of consciousness—Docetaxel—lung cancer	3.92e-05	0.000424	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Paclitaxel—lung cancer	3.91e-05	0.000424	CcSEcCtD
Dexamethasone—Insomnia—Paclitaxel—lung cancer	3.88e-05	0.00042	CcSEcCtD
Dexamethasone—Convulsion—Docetaxel—lung cancer	3.86e-05	0.000418	CcSEcCtD
Dexamethasone—Paraesthesia—Paclitaxel—lung cancer	3.85e-05	0.000417	CcSEcCtD
Dexamethasone—Hypertension—Docetaxel—lung cancer	3.85e-05	0.000417	CcSEcCtD
Dexamethasone—Prednisolone—ABCB1—lung cancer	3.85e-05	0.0246	CrCbGaD
Dexamethasone—Decreased appetite—Etoposide—lung cancer	3.8e-05	0.000412	CcSEcCtD
Dexamethasone—Myalgia—Docetaxel—lung cancer	3.79e-05	0.000411	CcSEcCtD
Dexamethasone—Nausea—Vinorelbine—lung cancer	3.79e-05	0.000411	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Etoposide—lung cancer	3.78e-05	0.000409	CcSEcCtD
Dexamethasone—Dyspepsia—Paclitaxel—lung cancer	3.78e-05	0.000409	CcSEcCtD
Dexamethasone—Body temperature increased—Cisplatin—lung cancer	3.78e-05	0.000409	CcSEcCtD
Dexamethasone—Asthenia—Irinotecan—lung cancer	3.77e-05	0.000409	CcSEcCtD
Dexamethasone—Fatigue—Etoposide—lung cancer	3.77e-05	0.000409	CcSEcCtD
Dexamethasone—Betamethasone—ABCB1—lung cancer	3.77e-05	0.0241	CrCbGaD
Dexamethasone—Pain—Etoposide—lung cancer	3.74e-05	0.000405	CcSEcCtD
Dexamethasone—Decreased appetite—Paclitaxel—lung cancer	3.73e-05	0.000404	CcSEcCtD
Dexamethasone—Haemoglobin—Methotrexate—lung cancer	3.71e-05	0.000402	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Paclitaxel—lung cancer	3.7e-05	0.000401	CcSEcCtD
Dexamethasone—Fatigue—Paclitaxel—lung cancer	3.7e-05	0.000401	CcSEcCtD
Dexamethasone—Haemorrhage—Methotrexate—lung cancer	3.69e-05	0.0004	CcSEcCtD
Dexamethasone—Asthenia—Gemcitabine—lung cancer	3.68e-05	0.000398	CcSEcCtD
Dexamethasone—Pain—Paclitaxel—lung cancer	3.67e-05	0.000398	CcSEcCtD
Dexamethasone—Anaphylactic shock—Docetaxel—lung cancer	3.64e-05	0.000394	CcSEcCtD
Dexamethasone—Oedema—Docetaxel—lung cancer	3.64e-05	0.000394	CcSEcCtD
Dexamethasone—Weight increased—Doxorubicin—lung cancer	3.63e-05	0.000394	CcSEcCtD
Dexamethasone—Pruritus—Gemcitabine—lung cancer	3.62e-05	0.000393	CcSEcCtD
Dexamethasone—Infection—Docetaxel—lung cancer	3.61e-05	0.000391	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—lung cancer	3.61e-05	0.000391	CcSEcCtD
Dexamethasone—Feeling abnormal—Etoposide—lung cancer	3.61e-05	0.000391	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—lung cancer	3.6e-05	0.00039	CcSEcCtD
Dexamethasone—Diarrhoea—Irinotecan—lung cancer	3.6e-05	0.00039	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Etoposide—lung cancer	3.58e-05	0.000388	CcSEcCtD
Dexamethasone—Shock—Docetaxel—lung cancer	3.58e-05	0.000388	CcSEcCtD
Dexamethasone—Nervous system disorder—Docetaxel—lung cancer	3.57e-05	0.000386	CcSEcCtD
Dexamethasone—Thrombocytopenia—Docetaxel—lung cancer	3.56e-05	0.000386	CcSEcCtD
Dexamethasone—Visual impairment—Methotrexate—lung cancer	3.55e-05	0.000385	CcSEcCtD
Dexamethasone—Tachycardia—Docetaxel—lung cancer	3.55e-05	0.000385	CcSEcCtD
Dexamethasone—Feeling abnormal—Paclitaxel—lung cancer	3.53e-05	0.000383	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Paclitaxel—lung cancer	3.51e-05	0.00038	CcSEcCtD
Dexamethasone—Diarrhoea—Gemcitabine—lung cancer	3.51e-05	0.00038	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—lung cancer	3.49e-05	0.000378	CcSEcCtD
Dexamethasone—Dizziness—Irinotecan—lung cancer	3.48e-05	0.000377	CcSEcCtD
Dexamethasone—Urticaria—Etoposide—lung cancer	3.48e-05	0.000377	CcSEcCtD
Dexamethasone—Anorexia—Docetaxel—lung cancer	3.47e-05	0.000376	CcSEcCtD
Dexamethasone—Body temperature increased—Etoposide—lung cancer	3.46e-05	0.000375	CcSEcCtD
Dexamethasone—Abdominal pain—Etoposide—lung cancer	3.46e-05	0.000375	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—lung cancer	3.46e-05	0.000375	CcSEcCtD
Dexamethasone—Eye disorder—Methotrexate—lung cancer	3.45e-05	0.000374	CcSEcCtD
Dexamethasone—Asthenia—Cisplatin—lung cancer	3.43e-05	0.000371	CcSEcCtD
Dexamethasone—Urticaria—Paclitaxel—lung cancer	3.41e-05	0.000369	CcSEcCtD
Dexamethasone—Hypotension—Docetaxel—lung cancer	3.4e-05	0.000368	CcSEcCtD
Dexamethasone—Abdominal pain—Paclitaxel—lung cancer	3.39e-05	0.000368	CcSEcCtD
Dexamethasone—Body temperature increased—Paclitaxel—lung cancer	3.39e-05	0.000368	CcSEcCtD
Dexamethasone—Angiopathy—Methotrexate—lung cancer	3.35e-05	0.000363	CcSEcCtD
Dexamethasone—Vomiting—Irinotecan—lung cancer	3.34e-05	0.000362	CcSEcCtD
Dexamethasone—Rash—Irinotecan—lung cancer	3.32e-05	0.000359	CcSEcCtD
Dexamethasone—Dermatitis—Irinotecan—lung cancer	3.31e-05	0.000359	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Docetaxel—lung cancer	3.31e-05	0.000359	CcSEcCtD
Dexamethasone—Headache—Irinotecan—lung cancer	3.3e-05	0.000357	CcSEcCtD
Dexamethasone—Insomnia—Docetaxel—lung cancer	3.29e-05	0.000356	CcSEcCtD
Dexamethasone—Diarrhoea—Cisplatin—lung cancer	3.27e-05	0.000354	CcSEcCtD
Dexamethasone—Paraesthesia—Docetaxel—lung cancer	3.26e-05	0.000354	CcSEcCtD
Dexamethasone—Alopecia—Methotrexate—lung cancer	3.26e-05	0.000353	CcSEcCtD
Dexamethasone—Vomiting—Gemcitabine—lung cancer	3.26e-05	0.000353	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—lung cancer	3.25e-05	0.000352	CcSEcCtD
Dexamethasone—Rash—Gemcitabine—lung cancer	3.23e-05	0.00035	CcSEcCtD
Dexamethasone—Dermatitis—Gemcitabine—lung cancer	3.23e-05	0.00035	CcSEcCtD
Dexamethasone—Erythema—Methotrexate—lung cancer	3.21e-05	0.000348	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—lung cancer	3.21e-05	0.000348	CcSEcCtD
Dexamethasone—Headache—Gemcitabine—lung cancer	3.21e-05	0.000348	CcSEcCtD
Dexamethasone—Dyspepsia—Docetaxel—lung cancer	3.2e-05	0.000347	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—lung cancer	3.19e-05	0.000346	CcSEcCtD
Dexamethasone—Decreased appetite—Docetaxel—lung cancer	3.16e-05	0.000343	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Docetaxel—lung cancer	3.14e-05	0.00034	CcSEcCtD
Dexamethasone—Asthenia—Etoposide—lung cancer	3.14e-05	0.00034	CcSEcCtD
Dexamethasone—Fatigue—Docetaxel—lung cancer	3.13e-05	0.00034	CcSEcCtD
Dexamethasone—Nausea—Irinotecan—lung cancer	3.12e-05	0.000339	CcSEcCtD
Dexamethasone—Pain—Docetaxel—lung cancer	3.11e-05	0.000337	CcSEcCtD
Dexamethasone—Pruritus—Etoposide—lung cancer	3.1e-05	0.000335	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—lung cancer	3.08e-05	0.000334	CcSEcCtD
Dexamethasone—Asthenia—Paclitaxel—lung cancer	3.08e-05	0.000334	CcSEcCtD
Dexamethasone—Nausea—Gemcitabine—lung cancer	3.04e-05	0.00033	CcSEcCtD
Dexamethasone—Vomiting—Cisplatin—lung cancer	3.04e-05	0.000329	CcSEcCtD
Dexamethasone—Pruritus—Paclitaxel—lung cancer	3.03e-05	0.000329	CcSEcCtD
Dexamethasone—Rash—Cisplatin—lung cancer	3.01e-05	0.000326	CcSEcCtD
Dexamethasone—Dermatitis—Cisplatin—lung cancer	3.01e-05	0.000326	CcSEcCtD
Dexamethasone—Feeling abnormal—Docetaxel—lung cancer	3e-05	0.000325	CcSEcCtD
Dexamethasone—Diarrhoea—Etoposide—lung cancer	2.99e-05	0.000324	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—lung cancer	2.98e-05	0.000323	CcSEcCtD
Dexamethasone—Ill-defined disorder—Methotrexate—lung cancer	2.98e-05	0.000323	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Docetaxel—lung cancer	2.97e-05	0.000322	CcSEcCtD
Dexamethasone—Hydrocortisone—ABCB1—lung cancer	2.94e-05	0.0188	CrCbGaD
Dexamethasone—Diarrhoea—Paclitaxel—lung cancer	2.94e-05	0.000318	CcSEcCtD
Dexamethasone—Angiopathy—Doxorubicin—lung cancer	2.9e-05	0.000314	CcSEcCtD
Dexamethasone—Malaise—Methotrexate—lung cancer	2.9e-05	0.000314	CcSEcCtD
Dexamethasone—Dizziness—Etoposide—lung cancer	2.89e-05	0.000314	CcSEcCtD
Dexamethasone—Vertigo—Methotrexate—lung cancer	2.88e-05	0.000313	CcSEcCtD
Dexamethasone—Body temperature increased—Docetaxel—lung cancer	2.87e-05	0.000312	CcSEcCtD
Dexamethasone—Abdominal pain—Docetaxel—lung cancer	2.87e-05	0.000312	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—lung cancer	2.85e-05	0.000309	CcSEcCtD
Dexamethasone—Dizziness—Paclitaxel—lung cancer	2.84e-05	0.000307	CcSEcCtD
Dexamethasone—Nausea—Cisplatin—lung cancer	2.84e-05	0.000307	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—lung cancer	2.82e-05	0.000306	CcSEcCtD
Dexamethasone—Convulsion—Methotrexate—lung cancer	2.78e-05	0.000302	CcSEcCtD
Dexamethasone—Vomiting—Etoposide—lung cancer	2.78e-05	0.000301	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—lung cancer	2.78e-05	0.000301	CcSEcCtD
Dexamethasone—Rash—Etoposide—lung cancer	2.76e-05	0.000299	CcSEcCtD
Dexamethasone—Dermatitis—Etoposide—lung cancer	2.76e-05	0.000299	CcSEcCtD
Dexamethasone—Headache—Etoposide—lung cancer	2.74e-05	0.000297	CcSEcCtD
Dexamethasone—Myalgia—Methotrexate—lung cancer	2.73e-05	0.000296	CcSEcCtD
Dexamethasone—Vomiting—Paclitaxel—lung cancer	2.73e-05	0.000296	CcSEcCtD
Dexamethasone—Rash—Paclitaxel—lung cancer	2.7e-05	0.000293	CcSEcCtD
Dexamethasone—Dermatitis—Paclitaxel—lung cancer	2.7e-05	0.000293	CcSEcCtD
Dexamethasone—Discomfort—Methotrexate—lung cancer	2.7e-05	0.000293	CcSEcCtD
Dexamethasone—Headache—Paclitaxel—lung cancer	2.69e-05	0.000291	CcSEcCtD
Dexamethasone—Anaphylactic shock—Methotrexate—lung cancer	2.62e-05	0.000284	CcSEcCtD
Dexamethasone—Asthenia—Docetaxel—lung cancer	2.61e-05	0.000283	CcSEcCtD
Dexamethasone—Infection—Methotrexate—lung cancer	2.6e-05	0.000282	CcSEcCtD
Dexamethasone—Nausea—Etoposide—lung cancer	2.6e-05	0.000282	CcSEcCtD
Dexamethasone—Ill-defined disorder—Doxorubicin—lung cancer	2.58e-05	0.00028	CcSEcCtD
Dexamethasone—Pruritus—Docetaxel—lung cancer	2.57e-05	0.000279	CcSEcCtD
Dexamethasone—Nervous system disorder—Methotrexate—lung cancer	2.57e-05	0.000279	CcSEcCtD
Dexamethasone—Thrombocytopenia—Methotrexate—lung cancer	2.57e-05	0.000278	CcSEcCtD
Dexamethasone—Nausea—Paclitaxel—lung cancer	2.55e-05	0.000276	CcSEcCtD
Dexamethasone—Hyperhidrosis—Methotrexate—lung cancer	2.53e-05	0.000275	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—lung cancer	2.51e-05	0.000272	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—lung cancer	2.5e-05	0.000271	CcSEcCtD
Dexamethasone—Anorexia—Methotrexate—lung cancer	2.5e-05	0.000271	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—lung cancer	2.49e-05	0.00027	CcSEcCtD
Dexamethasone—Diarrhoea—Docetaxel—lung cancer	2.49e-05	0.00027	CcSEcCtD
Dexamethasone—Hypotension—Methotrexate—lung cancer	2.45e-05	0.000265	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—lung cancer	2.44e-05	0.000265	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—lung cancer	2.41e-05	0.000261	CcSEcCtD
Dexamethasone—Dizziness—Docetaxel—lung cancer	2.4e-05	0.000261	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—lung cancer	2.4e-05	0.00026	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Methotrexate—lung cancer	2.39e-05	0.000259	CcSEcCtD
Dexamethasone—Insomnia—Methotrexate—lung cancer	2.37e-05	0.000257	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—lung cancer	2.37e-05	0.000257	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—lung cancer	2.36e-05	0.000256	CcSEcCtD
Dexamethasone—Paraesthesia—Methotrexate—lung cancer	2.35e-05	0.000255	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—lung cancer	2.34e-05	0.000253	CcSEcCtD
Dexamethasone—Vomiting—Docetaxel—lung cancer	2.31e-05	0.000251	CcSEcCtD
Dexamethasone—Dyspepsia—Methotrexate—lung cancer	2.31e-05	0.00025	CcSEcCtD
Dexamethasone—Rash—Docetaxel—lung cancer	2.29e-05	0.000248	CcSEcCtD
Dexamethasone—Dermatitis—Docetaxel—lung cancer	2.29e-05	0.000248	CcSEcCtD
Dexamethasone—Decreased appetite—Methotrexate—lung cancer	2.28e-05	0.000247	CcSEcCtD
Dexamethasone—Headache—Docetaxel—lung cancer	2.28e-05	0.000247	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—lung cancer	2.27e-05	0.000246	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—lung cancer	2.27e-05	0.000246	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Methotrexate—lung cancer	2.26e-05	0.000245	CcSEcCtD
Dexamethasone—Fatigue—Methotrexate—lung cancer	2.26e-05	0.000245	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—lung cancer	2.25e-05	0.000244	CcSEcCtD
Dexamethasone—Pain—Methotrexate—lung cancer	2.24e-05	0.000243	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—lung cancer	2.23e-05	0.000242	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—lung cancer	2.23e-05	0.000241	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—lung cancer	2.22e-05	0.000241	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—lung cancer	2.21e-05	0.00024	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—lung cancer	2.19e-05	0.000238	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—lung cancer	2.16e-05	0.000234	CcSEcCtD
Dexamethasone—Nausea—Docetaxel—lung cancer	2.16e-05	0.000234	CcSEcCtD
Dexamethasone—Feeling abnormal—Methotrexate—lung cancer	2.16e-05	0.000234	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Methotrexate—lung cancer	2.14e-05	0.000232	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—lung cancer	2.12e-05	0.00023	CcSEcCtD
Dexamethasone—Urticaria—Methotrexate—lung cancer	2.08e-05	0.000226	CcSEcCtD
Dexamethasone—Abdominal pain—Methotrexate—lung cancer	2.07e-05	0.000225	CcSEcCtD
Dexamethasone—Body temperature increased—Methotrexate—lung cancer	2.07e-05	0.000225	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.07e-05	0.000224	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—lung cancer	2.05e-05	0.000222	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—lung cancer	2.04e-05	0.000221	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—lung cancer	2e-05	0.000216	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—lung cancer	1.97e-05	0.000214	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—lung cancer	1.96e-05	0.000212	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—lung cancer	1.96e-05	0.000212	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—lung cancer	1.94e-05	0.00021	CcSEcCtD
Dexamethasone—Asthenia—Methotrexate—lung cancer	1.88e-05	0.000204	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—lung cancer	1.87e-05	0.000203	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—lung cancer	1.86e-05	0.000201	CcSEcCtD
Dexamethasone—Pruritus—Methotrexate—lung cancer	1.85e-05	0.000201	CcSEcCtD
Dexamethasone—Urticaria—Doxorubicin—lung cancer	1.8e-05	0.000195	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—lung cancer	1.79e-05	0.000194	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—lung cancer	1.79e-05	0.000194	CcSEcCtD
Dexamethasone—Diarrhoea—Methotrexate—lung cancer	1.79e-05	0.000194	CcSEcCtD
Dexamethasone—Dizziness—Methotrexate—lung cancer	1.73e-05	0.000188	CcSEcCtD
Dexamethasone—Vomiting—Methotrexate—lung cancer	1.67e-05	0.000181	CcSEcCtD
Dexamethasone—Rash—Methotrexate—lung cancer	1.65e-05	0.000179	CcSEcCtD
Dexamethasone—Dermatitis—Methotrexate—lung cancer	1.65e-05	0.000179	CcSEcCtD
Dexamethasone—Headache—Methotrexate—lung cancer	1.64e-05	0.000178	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—lung cancer	1.63e-05	0.000176	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—lung cancer	1.61e-05	0.000174	CcSEcCtD
Dexamethasone—Nausea—Methotrexate—lung cancer	1.56e-05	0.000169	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—lung cancer	1.55e-05	0.000168	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—lung cancer	1.5e-05	0.000163	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—lung cancer	1.44e-05	0.000156	CcSEcCtD
Dexamethasone—Rash—Doxorubicin—lung cancer	1.43e-05	0.000155	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—lung cancer	1.43e-05	0.000155	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—lung cancer	1.42e-05	0.000154	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—lung cancer	1.35e-05	0.000146	CcSEcCtD
Dexamethasone—CYP4A11—Metabolism—PIK3CA—lung cancer	1.25e-06	1.38e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTP1—lung cancer	1.25e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CYP1A1—lung cancer	1.25e-06	1.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CAT—lung cancer	1.24e-06	1.36e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ALB—lung cancer	1.24e-06	1.36e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—APOA1—lung cancer	1.24e-06	1.36e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ERCC2—lung cancer	1.24e-06	1.36e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.24e-06	1.36e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—APOA1—lung cancer	1.23e-06	1.35e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALDOA—lung cancer	1.23e-06	1.35e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—lung cancer	1.23e-06	1.35e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CAT—lung cancer	1.21e-06	1.33e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ABCB1—lung cancer	1.21e-06	1.33e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CB—lung cancer	1.21e-06	1.32e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CG—lung cancer	1.2e-06	1.32e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NCOA3—lung cancer	1.2e-06	1.31e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CB—lung cancer	1.19e-06	1.31e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—lung cancer	1.19e-06	1.31e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTEN—lung cancer	1.19e-06	1.3e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—TYMS—lung cancer	1.19e-06	1.3e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—lung cancer	1.18e-06	1.3e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.18e-06	1.3e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTP1—lung cancer	1.17e-06	1.29e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTM1—lung cancer	1.17e-06	1.29e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—APOA1—lung cancer	1.17e-06	1.28e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ADCY1—lung cancer	1.16e-06	1.28e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ABCG2—lung cancer	1.16e-06	1.28e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—lung cancer	1.16e-06	1.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTP1—lung cancer	1.16e-06	1.28e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TYMS—lung cancer	1.16e-06	1.27e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CG—lung cancer	1.15e-06	1.27e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MAPK3—lung cancer	1.15e-06	1.26e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTM1—lung cancer	1.15e-06	1.26e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTEN—lung cancer	1.14e-06	1.26e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CAT—lung cancer	1.14e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HPGDS—lung cancer	1.14e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ENO2—lung cancer	1.14e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—POMC—lung cancer	1.14e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.14e-06	1.25e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—EP300—lung cancer	1.13e-06	1.24e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CAT—lung cancer	1.13e-06	1.24e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—lung cancer	1.13e-06	1.24e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CG—lung cancer	1.13e-06	1.24e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MDM2—lung cancer	1.13e-06	1.24e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CG—lung cancer	1.13e-06	1.24e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.13e-06	1.24e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—RAF1—lung cancer	1.12e-06	1.23e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—lung cancer	1.12e-06	1.23e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.12e-06	1.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP1A1—lung cancer	1.11e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CREBBP—lung cancer	1.11e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB2—lung cancer	1.11e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ABCB1—lung cancer	1.11e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CA—lung cancer	1.11e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTT1—lung cancer	1.11e-06	1.22e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ERCC2—lung cancer	1.1e-06	1.21e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ABCB1—lung cancer	1.1e-06	1.21e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CB—lung cancer	1.1e-06	1.2e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MTOR—lung cancer	1.1e-06	1.2e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—POMC—lung cancer	1.1e-06	1.2e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD4—lung cancer	1.1e-06	1.2e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2A6—lung cancer	1.1e-06	1.2e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GCLC—lung cancer	1.1e-06	1.2e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CB—lung cancer	1.1e-06	1.2e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TYMS—lung cancer	1.09e-06	1.2e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—EP300—lung cancer	1.09e-06	1.2e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP1A1—lung cancer	1.09e-06	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—lung cancer	1.09e-06	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TYMS—lung cancer	1.08e-06	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTM1—lung cancer	1.08e-06	1.18e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ERCC2—lung cancer	1.08e-06	1.18e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—POMC—lung cancer	1.08e-06	1.18e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—POMC—lung cancer	1.07e-06	1.18e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTM1—lung cancer	1.07e-06	1.17e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CA—lung cancer	1.07e-06	1.17e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—APOA1—lung cancer	1.07e-06	1.17e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CREBBP—lung cancer	1.07e-06	1.17e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CG—lung cancer	1.06e-06	1.17e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CD—lung cancer	1.05e-06	1.16e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CREBBP—lung cancer	1.05e-06	1.15e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CREBBP—lung cancer	1.04e-06	1.15e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTEN—lung cancer	1.04e-06	1.14e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ALB—lung cancer	1.04e-06	1.14e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ENO1—lung cancer	1.04e-06	1.14e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—lung cancer	1.03e-06	1.14e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—lung cancer	1.03e-06	1.13e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTEN—lung cancer	1.03e-06	1.13e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.02e-06	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—lung cancer	1.02e-06	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP1A1—lung cancer	1.02e-06	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ERCC2—lung cancer	1.01e-06	1.11e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP1A1—lung cancer	1.01e-06	1.11e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CD—lung cancer	1.01e-06	1.11e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—POMC—lung cancer	1.01e-06	1.11e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ERCC2—lung cancer	1.01e-06	1.1e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ALB—lung cancer	1e-06	1.1e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—EP300—lung cancer	9.93e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CD—lung cancer	9.93e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CD—lung cancer	9.91e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—lung cancer	9.9e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CREBBP—lung cancer	9.87e-07	1.08e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—EP300—lung cancer	9.85e-07	1.08e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ALB—lung cancer	9.8e-07	1.08e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ALB—lung cancer	9.78e-07	1.07e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CG—lung cancer	9.76e-07	1.07e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—APOA1—lung cancer	9.54e-07	1.05e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1A—lung cancer	9.51e-07	1.04e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTEN—lung cancer	9.49e-07	1.04e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—lung cancer	9.47e-07	1.04e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTEN—lung cancer	9.46e-07	1.04e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CD—lung cancer	9.36e-07	1.03e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—APOA1—lung cancer	9.32e-07	1.02e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2E1—lung cancer	9.31e-07	1.02e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—POMC—lung cancer	9.29e-07	1.02e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CA—lung cancer	9.28e-07	1.02e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ALB—lung cancer	9.24e-07	1.01e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NQO1—lung cancer	9.21e-07	1.01e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CB—lung cancer	9.19e-07	1.01e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.14e-07	1e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—lung cancer	9.08e-07	9.96e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CREBBP—lung cancer	9.05e-07	9.93e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EP300—lung cancer	9.05e-07	9.93e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—EP300—lung cancer	9.02e-07	9.9e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CB—lung cancer	8.84e-07	9.69e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SRC—lung cancer	8.8e-07	9.65e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—APOA1—lung cancer	8.78e-07	9.63e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—lung cancer	8.75e-07	9.61e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—lung cancer	8.74e-07	9.59e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CG—lung cancer	8.71e-07	9.56e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—APOA1—lung cancer	8.7e-07	9.55e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CB—lung cancer	8.65e-07	9.5e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CB—lung cancer	8.64e-07	9.48e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CD—lung cancer	8.58e-07	9.42e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—lung cancer	8.57e-07	9.41e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—lung cancer	8.56e-07	9.39e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CG—lung cancer	8.5e-07	9.33e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—lung cancer	8.48e-07	9.31e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ALB—lung cancer	8.47e-07	9.3e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NRAS—lung cancer	8.46e-07	9.29e-06	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CA—lung cancer	8.39e-07	9.2e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.33e-07	9.14e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—STK11—lung cancer	8.3e-07	9.11e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—POMC—lung cancer	8.29e-07	9.1e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CB—lung cancer	8.16e-07	8.95e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAPK3—lung cancer	8.1e-07	8.89e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—POMC—lung cancer	8.1e-07	8.88e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—lung cancer	8.08e-07	8.87e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CREBBP—lung cancer	8.08e-07	8.86e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CA—lung cancer	8.08e-07	8.86e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CG—lung cancer	8.01e-07	8.79e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CG—lung cancer	7.95e-07	8.72e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PTEN—lung cancer	7.94e-07	8.72e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CREBBP—lung cancer	7.89e-07	8.65e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—lung cancer	7.88e-07	8.65e-06	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—lung cancer	7.77e-07	8.52e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—lung cancer	7.71e-07	8.46e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTP1—lung cancer	7.68e-07	8.43e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CD—lung cancer	7.66e-07	8.4e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTEN—lung cancer	7.63e-07	8.38e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—POMC—lung cancer	7.63e-07	8.37e-06	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—lung cancer	7.58e-07	8.32e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—EP300—lung cancer	7.58e-07	8.31e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—POMC—lung cancer	7.56e-07	8.3e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ALB—lung cancer	7.56e-07	8.3e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CB—lung cancer	7.48e-07	8.21e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTEN—lung cancer	7.48e-07	8.21e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CD—lung cancer	7.48e-07	8.2e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CAT—lung cancer	7.47e-07	8.2e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTEN—lung cancer	7.46e-07	8.19e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CREBBP—lung cancer	7.43e-07	8.15e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—lung cancer	7.41e-07	8.13e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ALB—lung cancer	7.38e-07	8.1e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CREBBP—lung cancer	7.37e-07	8.08e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CA—lung cancer	7.35e-07	8.06e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—lung cancer	7.28e-07	7.99e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CA—lung cancer	7.28e-07	7.99e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—EP300—lung cancer	7.28e-07	7.99e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ABCB1—lung cancer	7.27e-07	7.98e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TYMS—lung cancer	7.14e-07	7.83e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—EP300—lung cancer	7.13e-07	7.83e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—EP300—lung cancer	7.12e-07	7.81e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTM1—lung cancer	7.06e-07	7.74e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTEN—lung cancer	7.05e-07	7.74e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CD—lung cancer	7.05e-07	7.73e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CD—lung cancer	6.98e-07	7.66e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ALB—lung cancer	6.96e-07	7.63e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ALB—lung cancer	6.89e-07	7.57e-06	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—lung cancer	6.85e-07	7.52e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—EP300—lung cancer	6.72e-07	7.38e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CA—lung cancer	6.69e-07	7.34e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP1A1—lung cancer	6.69e-07	7.34e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CB—lung cancer	6.68e-07	7.33e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CA—lung cancer	6.68e-07	7.32e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ERCC2—lung cancer	6.63e-07	7.28e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—lung cancer	6.62e-07	7.26e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—lung cancer	6.6e-07	7.24e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CB—lung cancer	6.52e-07	7.15e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTEN—lung cancer	6.46e-07	7.09e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—lung cancer	6.46e-07	7.09e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—lung cancer	6.19e-07	6.79e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—EP300—lung cancer	6.16e-07	6.76e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CB—lung cancer	6.14e-07	6.74e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CB—lung cancer	6.09e-07	6.68e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—lung cancer	6.08e-07	6.68e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—lung cancer	6.03e-07	6.62e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—lung cancer	6e-07	6.59e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—lung cancer	5.95e-07	6.53e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—lung cancer	5.93e-07	6.5e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTEN—lung cancer	5.77e-07	6.33e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—APOA1—lung cancer	5.74e-07	6.3e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTEN—lung cancer	5.63e-07	6.18e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CA—lung cancer	5.6e-07	6.15e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—EP300—lung cancer	5.5e-07	6.04e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—lung cancer	5.47e-07	6e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—lung cancer	5.45e-07	5.98e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CA—lung cancer	5.39e-07	5.91e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—EP300—lung cancer	5.37e-07	5.89e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTEN—lung cancer	5.31e-07	5.82e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CA—lung cancer	5.28e-07	5.79e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CA—lung cancer	5.26e-07	5.78e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTEN—lung cancer	5.26e-07	5.77e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CG—lung cancer	5.24e-07	5.75e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—EP300—lung cancer	5.06e-07	5.55e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—EP300—lung cancer	5.02e-07	5.5e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—POMC—lung cancer	4.99e-07	5.47e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CA—lung cancer	4.97e-07	5.46e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CREBBP—lung cancer	4.86e-07	5.33e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CD—lung cancer	4.61e-07	5.05e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—lung cancer	4.58e-07	5.02e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CA—lung cancer	4.56e-07	5e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALB—lung cancer	4.55e-07	4.99e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—lung cancer	4.4e-07	4.83e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—lung cancer	4.31e-07	4.73e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—lung cancer	4.3e-07	4.72e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CA—lung cancer	4.07e-07	4.47e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—lung cancer	4.06e-07	4.46e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CB—lung cancer	4.01e-07	4.41e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—lung cancer	3.98e-07	4.37e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CA—lung cancer	3.97e-07	4.36e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CA—lung cancer	3.74e-07	4.11e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—lung cancer	3.73e-07	4.09e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CA—lung cancer	3.71e-07	4.07e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTEN—lung cancer	3.47e-07	3.81e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—lung cancer	3.32e-07	3.65e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—EP300—lung cancer	3.31e-07	3.63e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—lung cancer	3.25e-07	3.56e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—lung cancer	3.06e-07	3.36e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—lung cancer	3.03e-07	3.33e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CA—lung cancer	2.45e-07	2.69e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—lung cancer	2e-07	2.19e-06	CbGpPWpGaD
